MTOR and Birt-Hogg-Dube syndrome: Furuya et al. (10) found that pulmonary neoplasms of peripheral adenocarcinomatous lineage in BHD patients frequently exhibit loss of heterozygosity (LOH) of FLCN along with mTOR pathway activation.